Resolve Surgical Technologies

Based in Michigan, US, and founded in 1992, Resolve Surgical Technologies operates as a Medical Equipment Manufacturing company. In January 2025, In’Tech Medical SAS, a portfolio company of Montagu Private Equity and Tyber Medical, LLC a portfolio company of Montagu Private Equity merged into Resolve Surgical Technologies, a portfolio company of Montagu Private Equity. The firm, as of January 2025, is led by its President and CEO, Megan Dean Osorio. The medical device company delivers advanced solutions to OEM partners in the orthopedic and surgical sectors.

Operating under a Contract Development and Manufacturing Organization (CDMO+) model, Resolve combines contract design, development, manufacturing, and maintenance of surgical technologies with essential regulatory and clinical services. The company spans a broad range of specialties, including spine, trauma, cardiothoracic, and reconstructive surgery, offering both high-quality hardware products and comprehensive regulatory consulting. Its product portfolio includes cervical, thoracic, trauma, and cardiothoracic surgical instruments. Additionally, Resolve provides critical services such as regulatory compliance, clinical evaluations, and Quality Management System (QMS) integration, helping medical device companies navigate complex global standards.

The company's revenue is generated primarily through partnerships with OEMs and by offering regulatory, clinical, and manufacturing services globally.